XML 15 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 58,925,302 $ 250,728,118
Short-term investments 384,752,382 160,914,935
Accounts receivable 13,128,330 18,559,967
Accounts receivable from affiliated entities 722,941 503,782
Prepaid expenses and other current assets 84,592,179 40,357,456
Prepaid expenses and other current assets from affiliated entities 303,491 106,432
Total current assets 542,424,625 471,170,690
Fixed assets, net 18,111,288 11,348,144
Investment in affiliated entity 3,908,709 4,460,366
Investment in Geneos 0 434,387
Intangible assets, net 2,879,896 3,146,770
Goodwill 10,513,371 10,513,371
Operating lease right-of-use assets 12,173,414 12,741,296
Other assets 1,830,866 25,957,448
Total assets 591,842,169 539,772,472
Current liabilities:    
Accounts payable and accrued expenses 30,095,578 21,203,808
Accounts payable and accrued expenses due to affiliated entities 1,773,846 642,969
Accrued clinical trial expenses 10,416,164 9,950,345
Deferred revenue 109,128 46,628
Operating lease liability 2,463,878 2,329,394
Grant funding liability 6,859,155 7,474,310
Grant funding liability from affiliated entities 31,250 58,500
Total current liabilities 51,748,999 41,705,954
Deferred revenue, net of current portion 71,788 79,214
Operating lease liability, net of current portion 16,797,476 18,063,515
Deferred tax liabilities 32,046 32,046
Grant funding liability from affiliated entity, net of current portion 37,500 37,500
Other liabilities 64,141 57,663
Total liabilities 83,288,398 78,631,714
Stockholders’ equity:    
Preferred stock 0 0
Common stock 210,146 186,851
Additional paid-in capital 1,551,348,435 1,367,406,869
Accumulated deficit (1,042,738,901) (906,196,812)
Accumulated other comprehensive loss (265,909) (256,150)
Total Inovio Pharmaceuticals, Inc. stockholders’ equity 508,553,771 461,140,758
Total liabilities and stockholders’ equity 591,842,169 539,772,472
Convertible senior notes    
Current liabilities:    
Convertible debt 14,536,448 14,139,988
Convertible bonds    
Current liabilities:    
Convertible debt $ 0 $ 4,515,834